Canvas opinion around the medical and scientific communities as to the therapeutic areas presenting the greatest challenges for the pharmaceutical industry in the 21st Century, and the chances are that CNS disease (a term covering a broad spectrum of pathologies), oncology and HIV infection will be at the top of many people's lists. Whilst some significant advances have occurred in these therapeutic areas over the last decade, the continuing morbidity and mortality associated with a diagnosis in these areas confirms the need for new therapies.
|Number of pages||4|
|Journal||EBR - European Biopharmaceutical Review|
|Publication status||Published - Mar 2004|
ASJC Scopus subject areas
- Pharmaceutical Science